![Wafik El-Deiry: Some good reads in the August 23, 2024 issue of Science Magazine](https://oncodaily.com/pub/uploads/2024/08/El-Deiry-Wafik-Jan.-2019_0-e1708602153659-1-e1725228508882.png)
Wafik El-Deiry: Some good reads in the August 23, 2024 issue of Science Magazine
Wafik El-Deiry shared a post on LinkedIn:
“Some good reads in the August 23, 2024 issue of Science Magazine.
Great to see The National Institutes of Health Director Monica Bertagnolli comment about NIH taking action to repair relationship with Asian scientists in the US and elsewhere.
Enjoyed reading about decentralized clinical trials and some of their transformative innovative solutions WIN Consortium in cancer personalized medicine
Agree that scientists should get better at interacting with the media to communicate multi-dimensionality, and to handle sensitive or difficult topics.
There are other good articles on transgender health research, TIP60, Alzheimer’s and two articles about single molecule structure and dynamics.”
Source: Wafik El-Deiry/LinkedIn
More posts by Wafik El-Deiry on oncodaily.com
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023